West Pharmaceutical Services reported $81.5M in Selling and Administration Expenses for its second fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Align Technology ALGN:US $ 426.4M 13.06M
Atrion ATRI:US 8.01M 1.09M
Avanos Medical Inc AVNS:US $ 90.1M 14.9M
Baxter International BAX:US $ 817M 27M
Becton, Dickinson and BDX:US $ 1.15B 83M
Catalent CTLT:US $ 207M 21M
Cerus CERS:US $ 19.53M 1.2M
Charles River Laboratories CRL:US $ 131.71M 18.32M
Cooper Companies COO:US $ 322.4M 12.8M
Haemonetics HAE:US $ 85.56M 7.69M
Icu Medical ICUI:US $ 153.04M 71.76M
Insulet PODD:US $ 174.4M 45.7M
Integra Lifesciences IART:US $ 157.99M 6.97M
IQVIA Holdings Inc IQV:US $ 483M 5M
Johnson & Johnson JNJ:US $ 6.23B 288M
Medtronic MDT:US 2.57B 49M
Meridian Bioscience VIVO:US $ 21.33M 4.74M
Merit Medical Systems MMSI:US $ 85.49M 1.47M
Orasure Technologies OSUR:US $ 31.87M 4.31M
Repligen RGEN:US $ 54.65M 349K
Sientra SIEN:US 25.8M 3.24M
Staar Surgical STAA:US $ 29.21M 674K
Terumo 4543:JP 67.15B 3.63B
West Pharmaceutical Services WST:US $ 81.5M 1.9M